Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: SICAV
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: International

ACMBernstein SICAV - International Health Care Portfolio

+ Add to Watchlist

ACMHCII:LX

298.15 USD 1.66 0.55%

As of 00:59:30 ET on 03/03/2015.

Snapshot for ACMBernstein SICAV - International Health Care Portfolio (ACMHCII)

Year To Date: +9.12% 3-Month: +6.99% 3-Year: +22.18% 52-Week Range: 233.39 - 299.81
1-Month: +6.61% 1-Year: +18.90% 5-Year: +14.07% Beta vs MXWO0HC: 1.01

Mutual Fund Chart for ACMHCII

No chart data available.
  • ACMHCII:LX 298.15
  • 1M
  • 1Y
Interactive ACMHCII Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for ACMHCII

AllianceBernstein - International Health Care Portfolio is an open-end fund incorporated in Luxembourg. The Portfolio's objective is growth of capital. The Investment Manager expects that at any time at least 80% of the Portfolio's total assets will be invested in securities issued by companies principally engaged in health care and health care-related industries.

Inception Date: 02-17-1999 Telephone: -
Managers: JOHN FOGARTY / VINAY THAPAR
Web Site: www.abglobal.com

Fundamentals for ACMHCII

NAV (on 2015-03-03) 298.15
Assets (M) (on 2015-03-03) 428.16
Fund Leveraged N
Minimum Investment 1,000,000.00
Minimum Subsequent Investment -

Dividends for ACMHCII

No dividends reported

Fees & Expenses for ACMHCII

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 1.00
Redemption Fee 0.00
12b1 Fee -
Expense Ratio 1.51

Top Fund Holdings for ACMHCII

Filing Date: 01/31/2015
Name Position Value % of Total
Pfizer Inc 965,790 30,180,938 8.049%
Roche Holding AG 93,662 25,243,542 6.732%
GlaxoSmithKline PLC 1,126,360 24,801,004 6.614%
Novartis AG 234,920 22,893,611 6.105%
Gilead Sciences Inc 207,265 21,727,590 5.794%
Anthem Inc 126,760 17,107,530 4.562%
Medtronic PLC 226,167 16,148,324 4.306%
Johnson & Johnson 155,480 15,569,767 4.152%
Biogen Idec Inc 31,330 12,192,383 3.251%
Allergan Inc/United States 53,992 11,838,286 3.157%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil